Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect-site concentration of remifentanil to blunt cardiovascular responses to tracheal intubation during etomidate anesthesia
ChiCTR2100054565Phase 4Recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil, sponsored by Peking University Shenzhen Hospital. Primary endpoints: Blood pressure and Heart rate. Started Dec 2021; status: recruiting.
02
Drugs
remifentanil
Beyond the preview
Go deeper on ChiCTR2100054565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054565.